Active Ingredient(s): Amifostine
FDA Approved: * December 8, 1995
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Ethyol Overview

Amifostine (ethiofos) is a cytoprotective adjuvant used in cancer chemotherapy and radiotherapy involving DNA-binding chemotherapeutic agents. It is marketed by Clinigen Group under the trade name Ethyol. Contents 1 Indications 2 Pharmacokinetics 3 Mechanism of action 4 Adverse effects 5 Contraindications 6 References Indications Amifostine is used therapeutically to reduce the incidence of neutropenia-related fever and infection induced by DNA-binding chemotherapeutic agents including...

Read more Ethyol Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Ethyol Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 375mg/vial, 500mg, 500mg/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ethyol: (2 results)

Sorted by National Drug Code
  • 66220-017 Ethyol 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Cumberland Pharmaceuticals Inc.
  • 76310-017 Ethyol 500 mg/10ml Intravenous Injection, Powder, Lyophilized, for Solution by Clinigen Group Plc

Other drugs which contain Amifostine or a similar ingredient: (1 result)